Records 1 - 6
| Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
Bioscience reports 2020 Jul .
Xiong Ying, Bian Ce, Lin Xiaojuan, Wang Xiaoli, Xu Kehui, Zhao X
| A meta-analysis on associations of FTO, MTHFR and TCF7L2 polymorphisms with polycystic ovary syndrome.
Genomics 2019 Aug .
Wang Xiye, Wang Kaiping, Yan Juanying, Wu Miny
| Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with genetic susceptibility to polycystic ovary syndrome: A PRISMA-compliant meta-analysis.
Gene 2019 Aug 144079.
Zhu Xiaoyue, Hong Xiang, Chen Lusi, Xuan Yan, Huang Kaiping, Wang B
| Methylenetetrahydrofolate reductase C677T polymorphism and the risks of polycystic ovary syndrome: an updated meta-analysis of 14 studies.
Oncotarget 2017 Aug 8 (35): 59509-59517.
Wang Lihong, Xu Wenting, Wang Caihong, Tang Mengyu, Zhou Yuj
| Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
European journal of obstetrics, gynecology, and reproductive biology 2014 Apr 175 8-14.
Lee Young Ho, Song Gwan G
| Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.
European journal of obstetrics, gynecology, and reproductive biology 2014 Jan 172 56-61.
Fu Li-yuan, Dai Li-meng, Li Xiao-gang, Zhang Kun, Bai Y